体重指数与头颈癌患者的预后
研究在加拿大多伦多玛格丽特公主癌症中心纳入1279例侵袭性头颈鳞状细胞癌患者,评估诊断时或成年早期体重指数(BMI)与头颈癌结局的关联。中位随访2.5年,诊断时超重与正常体重者相比生存改善(HR 0.55;95%CI 0.4-0.8;p=.001),诊断时体重过低与更差结局相关(HR 1.89;95%CI 1.2-3.1;p<.01)。结论认为诊断时体重过低是独立的不良预后因素,而超重则预示较好预后;成年早期BMI与头颈癌结局无强关联。
要点
- 诊断时超重者较正常体重者生存改善:HR 0.55(95%CI 0.4-0.8;p=.001)。
- 诊断时体重过低者结局更差:HR 1.89(95%CI 1.2-3.1;p<.01)。
- 成年早期BMI与头颈癌结局无强关联。
核心结论
- 诊断时体重过低是独立的不良预后因素,而超重则预示较好预后;成年早期BMI与头颈癌结局无强关联。
研究设计与样本
- 在加拿大多伦多玛格丽特公主癌症中心对侵袭性头颈鳞状细胞癌患者进行烟草和酒精暴露、体能状态、合并症及诊断时BMI的调查,部分患者还收集了成年早期BMI数据,共分析1279例患者,中位随访2.5年。
主要发现
- 诊断时超重与正常体重者相比生存改善:HR 0.55(95%CI 0.4-0.8;p=.001)。
- 诊断时体重过低与更差结局相关:HR 1.89(95%CI 1.2-3.1;p<.01)。
- 成年早期BMI与头颈癌结局无强关联。
关键数值与推荐
- 诊断时超重 vs 正常体重:HR 0.55(95%CI 0.4-0.8;p=.001)。
- 诊断时体重过低 vs 正常体重:HR 1.89(95%CI 1.2-3.1;p<.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Body mass index (BMI) has been associated variably with head and neck cancer outcomes. We evaluated the association between BMI at either diagnosis or at early adulthood head and neck cancer outcomes. METHODS: Patients with invasive head and neck squamous cell cancer at Princess Margaret Cancer Centre in Toronto, Canada, were surveyed on tobacco and alcohol exposure, performance status, comorbidities, and BMI at diagnosis. A subset also had data collected for BMI at early adulthood. RESULTS: With a median follow-up of 2.5 years, in 1279 analyzed patients, being overweight (hazard ratio [HR], 0.55; 95% confidence interval [CI], 0.4-0.8; p = .001) at diagnosis was associated with improved survival when compared with individuals with normal weight. In contrast, underweight patients at diagnosis were associated with a worse outcome (HR, 1.89; 95% CI, 1.2-3.1; p < .01). CONCLUSION: Being underweight at diagnosis was an independent, adverse prognostic factor, whereas being overweight conferred better prognosis. BMI in early adulthood was not associated strongly with head and neck cancer outcomes. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1226-1233, 2017.
引用
- Gama RR, Song Y, Zhang Q, et al. Body mass index and prognosis in patients with head and neck cancer. Head Neck. 2017. PMID: 28323362. doi:10.1002/hed.24760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。